2. You have learned about the active ingredient in NutraSweet, aspartame, which is made from two...
1. a. Draw the Lewis dot structure for (CH3)2N (5 pts) b. Between CH,CH SH and CH, CH3NH2, which is a stronger Bronsted-Lowry acid? Account for the difference in acidity? (5 pts) 2. You have learned about the active ingredient in NutraSweet, aspartame, which is made from two amino acids; aspartic acid and phenylalanine. A related sweetener, alitame, is shown below: + oH NH2O N. OH a. Label all stereocenters with the appropriate (R) or (S) configuration. (6 pts) b....
g) Which structure is Z-2-bromo-3-methyl-2-pentene? CH3 H3C CH2CH3 H C=C CH-CH,CH, CH3 CH3 Вісн. C=C CH3 Br н Br | BÁ CHẠCH, C=C CH, CHỊCH, 10) Which compounds contain stereocenters? D) 1-chloropentane II) 2-chloropentane III) 3-chloropentane IV) 1,2-dichloropentane 11) Aspartame is an artificial, non-saccharide sweetener. It is made from two amino acids phenylalanine (methyl ester) and aspartic acid. Both aminoacids have one stercocenter. Both stereocenters have S-stereoconfiguration. Which of the two structures is aspartame? H2N-C-C-N-C-0-0 CH2 CH2 c=0 HO HO...
8. (3 pts.) In the section “designing the drug thalidomide”, you learned that researchers create various analogs to determine which structural features are necessary for biological activity and which are responsible for side effects. the analogs were created using the molecule shown below. using the information found in table 3, draw the corresponding analogs #7, 8, and 11. 8. (3 pts.) In the section Designing the Drug Thalidomide" you learned that researchers create various analogs to determine which structural features...
8. In the section "Designing the Drug Thalidomide", you learned that researchers create various analogues to determine which structural features are necessary for biological activity and which are responsible for side effects. The analogues were created using the molecule shown below. Using the information found in Tabkw 3, sraw the corresponding analogs #7, 8, and 11. 9. Thalidomide is known to be an inhibitor of TBF-a. TNF-a is a protein mediator, and when to much of this mediator is present,...